CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $2.5B, above the global median of $1.2B
- FinancialsAltman Z-Score 11: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
2.50BUSDvs all stocks (USD)
Revenue (TTM)
112.14MUSDvs all stocks (USD)
Profit Margin
-66.75%vs Medical Devices peers
Beta
2.09xvs all stocks
52-Week Change
379.09%vs all stocks
Market Capitalization
2.50BUSDvs all stocks (USD)
Enterprise Value
2.40BUSDvs all stocks (USD)
Forward P/E
-188.20xvs Medical Devices peers
Price to Sales (TTM)
22.34xvs Medical Devices peers
Price to Book (MRQ)
13.14xvs Medical Devices peers
Enterprise to Revenue
21.40xvs Medical Devices peers
Enterprise to EBITDA
-51.27xvs Medical Devices peers
Gross Margin
71.41%vs Medical Devices peers
Profit Margin
-66.75%vs Medical Devices peers
Operating Margin
-30.90%vs Medical Devices peers
Return on Assets (TTM)
-10.47%vs Medical Devices peers
Return on Equity (TTM)
-35.46%vs Medical Devices peers
Revenue (TTM)
112.14MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.4380USDUpdated Sep 27, 2026Quarterly Revenue Growth
39.50%vs Medical Devices peers
Gross Profit (TTM)
76.44MUSDvs all stocks (USD)
EBITDA (TTM)
-46.82MUSDvs all stocks (USD)
Net Income (TTM)
-74.85MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
39.47%vs Medical Devices peers
Operating Cash Flow (TTM)
-24.02MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
925.63KUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
97.61MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
51.88MUSDFY2025 · Dec 31, 2025Gross Profit
45.73MUSDFY2025 · Dec 31, 2025Operating Income
-86.42MUSDvs all stocks (USD)
Pre-tax Income
-76.95MUSDFY2025 · Dec 31, 2025Income Tax Expense
110.00KUSDFY2025 · Dec 31, 2025Net Income
-77.06MUSDFY2025 · Dec 31, 2025EBIT
-75.46MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-69.66MUSDFY2025 · Dec 31, 2025Research & Development
36.26MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
95.89MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
5.91MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.49MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.3100USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.3100USDFY2025 · Dec 31, 2025Basic Shares Outstanding
247.12MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
247.12MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-77.06MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-35.40MUSDFY2025 · Dec 31, 2025Free Cash Flow
-38.75MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
154.50MUSDFY2025 · Dec 31, 2025Interest Paid
810.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-77.06MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
8.08MUSDFY2025 · Dec 31, 2025Stock-based Compensation
23.43MUSDFY2025 · Dec 31, 2025Other Non-cash Items
2.29MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.75MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.20MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
13.42MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.35MUSDFY2025 · Dec 31, 2025Purchase of Investments
0.00USDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.35MUSDFY2025 · Dec 31, 2025Other Financing Charges
-5.47MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
75.53MUSDFY2025 · Dec 31, 2025Shares Outstanding
264.42MSharesUpdated Sep 27, 2026Float Shares
219.93MSharesUpdated Sep 27, 2026Shares Short
34.06MSharesUpdated Sep 27, 2026Short Ratio
5.70daysvs all stocks
Short % of Shares Outstanding
15.92%vs all stocks
% Held by Insiders
10.26%vs all stocks
% Held by Institutions
61.50%vs all stocks
Total Cash (MRQ)
124.66MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.4680USDUpdated Sep 27, 2026Total Debt (MRQ)
19.10MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1008xvs Medical Devices peers
Current Ratio (MRQ)
4.06xvs Medical Devices peers
Book Value per Share (MRQ)
0.7160USDUpdated Sep 27, 2026Total Assets
296.53MUSDvs all stocks (USD)
Total Current Assets
249.10MUSDFY2025 · Dec 31, 2025Total Liabilities
100.55MUSDFY2025 · Dec 31, 2025Total Non-current Assets
47.43MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
35.44MUSDFY2025 · Dec 31, 2025Total Current Liabilities
65.12MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
150.49MUSDFY2025 · Dec 31, 2025Accounts Receivable
26.74MUSDFY2025 · Dec 31, 2025Inventory
61.39MUSDFY2025 · Dec 31, 2025Accounts Payable
5.44MUSDFY2025 · Dec 31, 2025Short-term Debt
2.68MUSDFY2025 · Dec 31, 2025Deferred Revenue
26.91MUSDFY2025 · Dec 31, 2025Other Current Liabilities
9.71MUSDFY2025 · Dec 31, 2025Long-term Debt
17.72MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
8.32MUSDFY2025 · Dec 31, 2025Common Stock (Book)
26.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-879.19MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
195.98MUSDvs all stocks (USD)
52-Week Low
1.86USDUpdated Sep 27, 202652-Week High
10.05USDUpdated Sep 27, 202652-Week Change
379.09%vs all stocks
Beta
2.09xvs all stocks
50-Day MA
8.05USDUpdated Sep 27, 2026200-Day MA
5.46USDUpdated Sep 27, 2026Avg 10-Day Volume
6.73MSharesUpdated Sep 27, 2026Avg 30-Day Volume
5.22MSharesUpdated Sep 27, 2026Diluted EPS (TTM)
-0.2900USDUpdated Sep 27, 2026Other Income / Expense
5.04MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.40Receivables vs revenue divergence: 2.54
High gross margins eroded by operating costsNotable
Gross Margin: 0.71Profit Margin: -0.67
Financial Health
Altman Z-Score 11: safe zoneNotable
Altman Z-Score: 11.00
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $2.5B, above the global median of $1.2BNotable
Market cap (USD): 2,500,417,868Global Median: 1,201,862,193
Companies that share the same coordination system — how they create, deliver, or capture value.
China Resources Double Crane Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Disc Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Beam Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
GN Store Nord A/S
Tier 1ProductionApproval-Gated PipelineRuleFlow
Supernus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Heron Neutron Medical Corp.
Tier 1ProductionApproval-Gated PipelineRule
HUTCHMED
Tier 1ProductionApproval-Gated PipelineRule
Pharma Research Products Co., Ltd
Tier 1ProductionApproval-Gated PipelineRule
Axogen Inc.
Tier 1ProductionApproval-Gated PipelineRule
Double Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule